MDS Diagnostic Services In Discussions to Sell Interest in Calgary Laboratory Services Partnership
06 Dicembre 2005 - 2:02PM
PR Newswire (US)
TORONTO, Dec. 6 /PRNewswire-FirstCall/ -- MDS Diagnostic Services,
a division of MDS Inc. (TSX: MDS; NYSE: MDZ), a company providing a
range of enabling products and services to the global life sciences
markets, today announced that it is in discussions to sell its
interest in the Calgary Laboratory Services partnership to the
Calgary Health Region. A business agreement is under negotiation
and is expected to be signed later this month. Under the terms of
the agreement, the Calgary Health Region would purchase MDS's 25%
interest in Calgary Laboratory Services. In 2005, MDS Diagnostic
Services recorded approximately $70 million in revenues and $1.5
million in net income related to this partnership. Completion of
the transaction would be subject to approval by the Calgary Health
Region Board and Alberta Health and Wellness. MDS Diagnostic
Services, a business unit of MDS Inc., is a leading provider of
laboratory testing and management services. MDS Inc. has more than
8,800 highly skilled people in 27 countries. We provide a diverse
range of superior products and services to increase our customers'
speed, precision and productivity in the drug development and
disease diagnosis processes. We are a global, values-driven health
and life sciences company, recognized for our reliability and
collaborative relationships as we help create better outcomes in
the treatment of disease. Find out more at http://www.mdsinc.com/
or by calling 1-888-MDS-7222, 24 hours a day. This document
contains forward-looking statements. Some forward-looking
statements may be identified by words like "expects",
"anticipates", "plans", "intends", "indicates" or similar
expressions. The statements are not a guarantee of future
performance and are inherently subject to risks and uncertainties.
The Company's actual results could differ materially from those
currently anticipated due to a number of factors, including, but
not limited to, successful integration of structural changes,
including restructuring plans, acquisitions, technical or
manufacturing or distribution issues, the competitive environment
for the Company's products, the degree of market penetration of the
Company's products, and other factors set forth in reports and
other documents filed by the Company with Canadian and US
securities regulatory authorities from time to time. DATASOURCE:
MDS Inc.; MDS Diagnostic Services CONTACT: Investor: Yvette Lokker,
Manager, Investor Relations, (416) 675-6777 ext. 2993, ; Media:
Norm Berberich, Senior Manager, Communications, (416) 675-6777 ext.
2800,
Copyright